{
    "ticker": "VAPO",
    "name": "Vapotherm, Inc.",
    "description": "Vapotherm, Inc. is a leading provider of high-velocity nasal insufflation (HVNI) technology for the treatment of respiratory distress in patients. Founded in 2003 and headquartered in Exeter, New Hampshire, Vapotherm is dedicated to advancing respiratory care through innovative technologies that improve patient outcomes. The company's proprietary Vapotherm Precision Flow system offers a non-invasive solution that delivers heated and humidified oxygen to patients, helping to alleviate respiratory distress in various clinical settings, including hospitals and outpatient facilities. Vapotherm's technology has been clinically validated and is used in the management of conditions such as COPD, asthma, and COVID-19. The company is committed to ongoing research and development, aiming to expand its product offerings and improve patient care through enhanced respiratory support solutions. Vapotherm operates in a growing market, driven by the rising prevalence of respiratory diseases and an increasing demand for effective non-invasive treatment options. With a focus on innovation and quality, Vapotherm is positioned to make a significant impact in the field of respiratory therapy.",
    "industry": [
        "Healthcare",
        "Medical Devices"
    ],
    "headquarters": "Exeter, New Hampshire, USA",
    "founded": "2003",
    "website": "https://www.vapotherm.com",
    "ceo": "John L. McDonough",
    "social_media": {
        "twitter": "https://twitter.com/Vapotherm",
        "linkedin": "https://www.linkedin.com/company/vapotherm/"
    },
    "investor_relations": "https://investors.vapotherm.com",
    "key_executives": [
        {
            "name": "John L. McDonough",
            "position": "CEO"
        },
        {
            "name": "David E. W. H. Nussbaum",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Respiratory Care Devices",
            "products": [
                "Precision Flow"
            ]
        }
    ],
    "seo": {
        "meta_title": "Vapotherm, Inc. | Innovative Respiratory Care Solutions",
        "meta_description": "Explore Vapotherm, Inc., a leader in high-velocity nasal insufflation technology for respiratory care. Discover their innovative products and commitment to improving patient outcomes.",
        "keywords": [
            "Vapotherm",
            "Respiratory Care",
            "Medical Devices",
            "Nasal Insufflation",
            "Precision Flow"
        ]
    },
    "faq": [
        {
            "question": "What is Vapotherm known for?",
            "answer": "Vapotherm is known for its innovative high-velocity nasal insufflation technology for treating respiratory distress."
        },
        {
            "question": "Who is the CEO of Vapotherm?",
            "answer": "John L. McDonough is the CEO of Vapotherm, Inc."
        },
        {
            "question": "Where is Vapotherm headquartered?",
            "answer": "Vapotherm is headquartered in Exeter, New Hampshire, USA."
        },
        {
            "question": "What are Vapotherm's main products?",
            "answer": "Vapotherm's main product is the Precision Flow system for non-invasive respiratory support."
        },
        {
            "question": "When was Vapotherm founded?",
            "answer": "Vapotherm was founded in 2003."
        }
    ],
    "competitors": [
        "NVCR",
        "HIMX",
        "PHMD"
    ],
    "related_stocks": [
        "ABBV",
        "JNJ",
        "MDT",
        "BMY"
    ]
}